Page last updated: 2024-09-02

tadalafil and cetylpyridinium chloride anhydrous

tadalafil has been researched along with cetylpyridinium chloride anhydrous in 1 studies

Compound Research Comparison

Studies (tadalafil)	Trials (tadalafil)	Recent Studies (post-2010) (tadalafil)	Studies (cetylpyridinium chloride anhydrous)	Trials (cetylpyridinium chloride anhydrous)	Recent Studies (post-2010) (cetylpyridinium chloride anhydrous)
1,742	392	1,089	25,027	583	4,304

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldari, C; Bianchini, S; Di Luigi, L; Emerenziani, GP; Gallotta, MC; Guidetti, L; Lenzi, A; Pigozzi, F; Romanelli, F; Sgrò, P	1

Trials

1 trial(s) available for tadalafil and cetylpyridinium chloride anhydrous

Article	Year
The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men. The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:9 Topics: Adult; Carbolines; Cross-Over Studies; Dehydroepiandrosterone Sulfate; Double-Blind Method; Exercise; Health; Humans; Hydrocortisone; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Placebos; Saliva; Stress, Physiological; Tadalafil; Testosterone	2008

Article

Year

The type 5 phosphodiesterase inhibitor tadalafil influences salivary cortisol, testosterone, and dehydroepiandrosterone sulphate responses to maximal exercise in healthy men.

The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:9

Topics: Adult; Carbolines; Cross-Over Studies; Dehydroepiandrosterone Sulfate; Double-Blind Method; Exercise; Health; Humans; Hydrocortisone; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Placebos; Saliva; Stress, Physiological; Tadalafil; Testosterone

2008